Twelve Peptostreptococcus stomatis coccoid bodies appear in seven groupings: three singles, three touching pairs, and one three-body chain.
Species morphology reconstruction Editorially reviewed

Type-strain-anchored Peptostreptococcus stomatis reconstruction showing twelve coccoid bodies in three single, three paired, and one three-body chain grouping. This species plate is representative, non-diagnostic, and not a micrograph.

WikiBiome / Microbiome MedicineCurrent-species-taxonomy-, nomenclature-, type-strain-, and primary-description-informed reconstruction
Scientific media record1 verified identifier
Subject
Peptostreptococcus stomatistaxon · species
Review
Editorial review completeIdentifiers authority-verified · Accessibility validated · · peptostreptococcus-stomatis|peptostreptococcus-stomatis-morphology-v1.webp
Digital source
Trained-algorithmic mediaCreated with a trained generative algorithm and reviewed by WikiBiome for subject identity, scientific framing, identifiers, provenance, and accessibility.
License
CC BY-SA 4.0Created

Peptostreptococcus stomatis is a Gram-positive, obligately anaerobic coccus originally isolated from the human oral cavity (oral streptococcal species) that has emerged as a carcinogenic oral pathobiont enriched in colorectal cancer, particularly in advanced stages.

Unlike commensal oral streptococci, P. stomatis carries a polyketide synthase (pks) gene cluster homologous to colibactin biosynthesis operon found in pathogenic Escherichia coli strains, enabling it to produce colibactin and related genotoxic metabolites that cause DNA double-strand breaks in colonocytes.

This makes P. stomatis a direct contributor to the molecular carcinogenesis pathway in CRC, operating as a member of the oral-colorectal carcinogenic consortium alongside Fusobacterium nucleatum, Parvimonas micra, and Clostridium symbiosum. Its abundance correlates with advanced adenoma stage and presence of colibactin-associated DNA lesions (γH2AX foci in colonocyte nuclei).

Contents1. Taxonomy and Basic Properties2. Colibactin Biosynthesis and Genotoxin Production3. Iron Dependency and Growth Characteristics4. Role in Colorectal Cancer and Carcinogenic Consortium5. Distinction from Non-Pathogenic Streptococci6. Detection and Quantification7. Typical Abundance Ranges8. Connections to WikiBiome Entities and Disease Signatures

Taxonomy and Basic Properties#

  • Phylum: Firmicutes
  • Class: Clostridia
  • Order: Clostridiales
  • Family: Peptoniphilaceae
  • Genus: Peptostreptococcus
  • Species: Peptostreptococcus stomatis
  • Cell Type: Coccus (round); obligate anaerobe; non-motile
  • Gram Stain: Positive (thick peptidoglycan; no outer membrane)
  • Cell Size: 0.5–1.0 µm diameter (similar to Parvimonas micra; small for Gram-positive cocci)
  • Genome: ~3.2 Mb (complete genome available)
  • pks Cluster Status: Carries homologous pks gene cluster (53–55 kb) nearly identical to E. coli enterobacteria-specific pathogenicity island (ECPAT)

Colibactin Biosynthesis and Genotoxin Production#

Polyketide Synthase (pks) Gene Cluster#

P. stomatis harbors a pks operon encoding colibactin biosynthesis enzymes, making it one of the few non-Enterobacteriaceae bacteria capable of producing this compound. The pks cluster contains.

Polyketide synthase (PksA, PksB): Condensation and elongation of polyketide backbone. Tailoring enzymes: Cyclization, reduction, oxidation of intermediates. Transport/export systems: Secretion of mature colibactin across bacterial cell membrane.

Phylogenetic analysis suggests P. stomatis acquired the pks cluster via horizontal gene transfer from pathogenic E. coli strains, indicating a shared carcinogenic ancestry between oral and enteric genotoxigenic pathogens.

Colibactin Structure and Mechanism#

Colibactin is a hybrid polyketide-nonribosomal peptide (~1000 Da; partially characterized structure):

`` Colibactin (mature form) ↓ (secretion; uncertain cellular target) ↓ (proposed: cellular internalization via endocytosis or transporter) → Nuclear translocation [uncertain mechanism; possibly through nucleoporin disruption] → DNA binding / intercalation → Formation of DNA adducts (premutagenic lesions) → Replication fork stalling → Double-strand break (DSB) formation via replication machinery collision → γH2AX (histone 2AX phosphorylation) at DSB sites → p53 activation / cell cycle arrest / apoptosis (acute) → Genomic instability / aberrant DNA repair / mutation fixation (chronic) ``

Cellular Effects in Colonocytes#

EffectMechanismConsequence
DNA Double-Strand Breaks (DSBs)Colibactin-DNA adduct + replication fork collisionγH2AX foci; p53 activation
Genomic InstabilityAberrant DSB repair (non-homologous end-joining errors)Mutations in APC, KRAS, TP53
Inflammatory ResponseDSBs trigger TLR9 and cGAS-STING innate immune signalingIL-6, IL-17 production; Th17 polarization
Cell Cycle Arrest/Apoptosisp53-dependent senescence or programmed cell deathEpithelial shedding; cryptal hyperplasia
MutagenesisFixed mutations in surviving cellsAdenoma initiation; clonal expansion

The combination of direct genotoxicity + inflammatory amplification makes colibactin-producing P. stomatis a potent carcinogen; its effect on CRC risk is dose-dependent and strain-specific based on pks cluster expression level.

Iron Dependency and Growth Characteristics#

Iron Acquisition#

  • P. stomatis is iron-dependent; requires iron(II) (Fe2+)/iron(III) for:
  • Cytochrome biosynthesis (anaerobic electron transport)
  • Iron-sulfur cluster assembly
  • Polyketide synthase cofactor maturation (some PKS enzymes require iron-coordination)
  • No siderophore production (unlike Parvimonas micra); relies on scavenging ferrous iron from the colonic lumen and competing with host hepcidin.

Growth in the CRC Microenvironment#

Obligate anaerobe: Inhibited by O2 >5 ppm; thrives in biofilms and mucin-rich colonic crypts. Biofilm-integrated: Does not form independent biofilms but integrates into polymicrobial biofilms nucleated by Parvimonas micra and Fusobacterium nucleatum.

Slow grower: Doubling time ~6–8 hours; slower than E. coli but faster than methanogens. In dense biofilms, growth is limited by nutrient/oxygen flux.

Role in Colorectal Cancer and Carcinogenic Consortium#

Stage-Dependent Enrichment#

Unlike Parvimonas micra and Fusobacterium nucleatum which enrich early (in adenomas), P. stomatis shows stage-dependent enrichment:

  • Healthy adults: <10^3 copies/g feces; minimal
  • Advanced adenoma (AJCC stage III): 10^4–10^6 copies/g feces (emerging enrichment)
  • Incident CRC: 10^6–10^8 copies/g feces (dramatic enrichment)
  • Advanced CRC (stage IV, metastatic): 10^7–10^9 copies/g feces (peak abundance)

This stage-specific enrichment pattern suggests P. stomatis accelerates the adenoma-to-carcinoma transition rather than initiating adenoma formation.

Oral-Colorectal Translocation and Pathobiont Consortium#

P. stomatis follows the same oral-colorectal axis as Parvimonas micra:

  1. Oral origin: Normal oral microbiota; enriched in periodontal disease.
  2. Periodontitis → intestinal Dysbiosis: Periodontal pathogens (including P. stomatis) → chronic Metal-Driven Inflammation → intestinal barrier disruption.
  3. Translocation: Leaky gut → bacteremia → fecal reseeding → colon recolonization.
  4. Biofilm integration: In dysbiotic colon, P. stomatis integrates into polymicrobial CRC biofilms:
PartnerSynergistic Role
Parvimonas micraBiofilm nucleator; iron scavenger; direct epithelial adhesin; supports P. stomatis microaerophilic niche
Fusobacterium nucleatumFadA invasin; barrier breacher; further enables colibactin penetration to epithelium
Clostridium symbiosumBile acid metabolism → chronic inflammation; suppressed Butyrate → lower pH → favors anaerobic P. stomatis growth
Toxigenic Bacteroides fragilis (BFT+)BFT toxin → epithelial barrier disruption; reduced epithelial integrity enables colibactin access to nuclei
pks+ Escherichia coli (AIEC, EAEC)Synergistic colibactin production; redundant genotoxicity

Colibactin-Mediated Carcinogenesis#

The CRC signature associated with P. stomatis includes. Elevated colibactin-specific DNA lesions: γH2AX+ colonocytes; pks-specific DNA adducts (detectable by LC-MS). Th17-skewed immunity: IL-17, IL-6 elevation; reduced IL-22 (gut barrier-protective cytokine).

APC mutations: Adenomatous polyposis coli (APC) gene disruption via colibactin-induced mutagenesis; truncating APC mutations enable adenoma initiation.

Field defect: Pre-neoplastic mucosa surrounding the tumor shows colibactin-induced DNA damage; indicates field carcinogenesis (multifocal transformation risk).

Distinction from Non-Pathogenic Streptococci#

P. stomatis is often confused with commensal oral streptococci (e.g., Streptococcus anginosus, S. viridans) because both originate from the oral cavity. Key differences:

FeatureP. stomatis (pks+)Commensal Streptococci
pks Gene ClusterYes; encodes colibactinNo
GenotoxicityPotent; causes DSBsNone
CRC EnrichmentDramatic; stage-dependentMinimal or none
Virulence FactorsMultiple (colibactin, proteases)Limited (hyaluronidase, streptokinase)
Periodontal AssociationStrong; enriched in periodontitisWeak; found in health and disease
DNA Damage SignatureγH2AX+ foci in colonocytesNo epithelial DNA damage

Note: P. stomatis is likely a heterogeneous genus. Not all Peptostreptococcus strains carry the pks cluster; some P. stomatis isolates may be non-pathogenic. Clinical studies should ideally perform pks gene PCR or whole-genome sequencing to distinguish pathogenic (pks+) from non-pathogenic (pks-) strains.

Detection and Quantification#

Molecular Methods#

16S rRNA gene sequencing: Peptostreptococcus stomatis-specific primers; genus-level Peptostreptococcus detection is common, but species-level differentiation requires careful design. pks Gene PCR: Targets the polyketide synthase operon; distinguishes pks+ (genotoxigenic) from pks- strains. Shotgun metagenomics: P. stomatis genome is sequenced; read abundance correlates with qPCR. pks gene presence detectable in metagenomes.

qPCR: Species-specific 16S assays; pks-specific assays available in research settings.

Functional Assays#

Colibactin Detection: Bioassay on target cells (colonocyte lines) → genotoxicity (γH2AX); mass spectrometry for direct colibactin quantification (research setting). γH2AX Immunohistochemistry: Stain colonic biopsies with anti-γH2AX antibodies; visualize DNA damage foci in epithelium of P. stomatis-colonized patients.

Culture-Based Methods#

Anaerobic culture: Grows on Brucella agar + blood under 85% N2 / 10% H2 / 5% CO2; slower than Parvimonas micra. Colony morphology: Small (0.5–1 mm), translucent, mucoid colonies; similar to other Peptostreptococcus spp. 16S rRNA sequencing or MALDI-TOF mass spectrometry: Confirms identity.

pks PCR: Determines genotoxigenic potential.

Typical Abundance Ranges#

PopulationP. stomatis (copies/g feces; % microbiota)Notes
Healthy adults<10^3 (<0.001%)Minimal; oral carriage only
Periodontal disease patients10^3–10^5 (0.01–0.1%)Elevated in mouth; oral origin
Adenoma patients (early stage)10^3–10^4 (<0.1%)Minimal enrichment
Advanced adenoma (stage III+)10^4–10^6 (0.1–1%)Begin to enrich; integration into biofilms
Incident CRC10^6–10^8 (1–5%)Dramatic enrichment; peak genotoxic activity
Advanced CRC (stage IV)10^7–10^9 (2–10%)Very high abundance; strong biomarker

Connections to WikiBiome Entities and Disease Signatures#

– Product; polyketide genotoxin; directly causes DNA double-strand breaks. – Gene cluster (pks); encodes colibactin biosynthesis. DNA Damage in Metal Carcinogenesis – Primary mechanistic output; γH2AX foci, mutations in APC/KRAS/TP53.

– Colibactin acts as a genotoxin; mutagen and carcinogen. Colorectal Cancer – Dramatically enriched; carcinogenic consortium member. – Enriched in advanced adenomas; drives adenoma-to-carcinoma transition.

Iron – Required for growth; iron-dependent; no siderophores produced. – Originates in oral cavity; translocates to colon. – Enriched in periodontal disease; periodontal disease correlates with CRC risk.

inflammation – Colibactin-induced DSBs trigger TLR9/cGAS-STING; Th17 polarization. Biofilm – Integrates into polymicrobial CRC biofilms (nucleated by Parvimonas micra); does not form independent biofilms. Parvimonas micra – Biofilm partner; nucleates structure that houses P. stomatis.

Fusobacterium nucleatum – Biofilm partner; FadA invasin facilitates colibactin epithelial penetration. Clostridium symbiosum – Biofilm partner; bile acid metabolism amplifies inflammation. Bacteroides fragilis (BFT+ strains) – Biofilm partner; toxin-driven barrier disruption enables colibactin access.

Escherichia coli (pks+ strains) – Evolutionary source of pks cluster; synergistic genotoxicity if both present. dysbiosis – Enriched in dysbiotic CRC microbiota; suppressed in healthy, butyrate-dominated microbiota. – IL-17-driven immune response to colibactin-induced DSBs.

– Downstream of colibactin-induced DNA damage; tumor suppressor response.

Peptostreptococcus stomatis exemplifies how oral pathogens, when equipped with carcinogenic metabolites (colibactin), translocate to the colon and become drivers of malignant transformation through direct DNA-damaging mechanisms integrated into a polymicrobial consortium.

Generated evidence record

References 8

Numbered by first appearance in the article, then reconciled with its declared source list.

  1. 1

    Marius Troeseid, Susanne Dam Nielsen, Ivan Vujkovic-Cvijin (2024). Gut microbiome and cardiometabolic comorbidities in people living with HIV. Microbiome.

  2. 2

    Youwen Qin, Xin Tong, Wei-Jian Mei et al. (2024). Consistent signatures in the human gut microbiome of old- and young-onset colorectal cancer. Nature Communications.

  3. 3

    Zangeneh Z, Abdi-Ali A, Khamooshian K et al. (2021). Bacterial Variation in the Oral Microbiota in Multiple Sclerosis Patients. PLoS ONE.

  4. 4

    Saito K, Koido S, Odamaki T et al. (2019). Metagenomic Analyses of the Gut Microbiota Associated with Colorectal Adenoma. PLOS ONE.

  5. 5

    Qian Yang, Yaping Wang, Xinyi Wei et al. (2020). Yang 2020 — Vaginal Microbiome Alterations in HPV16 Infection by Shotgun Metagenomics. Frontiers in Cellular and Infection Microbiology.

  6. 6

    Zhiguang Gao, Bomin Guo, Renyuan Gao et al. (2015). Microbiota disbiosis is associated with colorectal cancer. Frontiers in Microbiology.

  7. 7

    Hanus M, Parada-Venegas D, Landskron G et al. (2021). Immune System, Microbiota, and Microbial Metabolites: The Unresolved Triad in Colorectal Cancer Microenvironment. Frontiers in Immunology.

  8. 8

    Filipe T. Lira Neto, Marina C. Viana, Federica Cariati et al. (2024). Neto 2024 — Effect of Environmental Factors on Seminal Microbiome and Impact on Sperm Quality. Frontiers in Endocrinology.

Knowledge graph

Article network

Researcher discussion

Connect the evidence

Publicly readable discussion by ORCID-authenticated researchers. Questions, interpretation, methods, corrections, and new evidence stay attached to this record.

0 posts

No discussion yet. Start with a precise question or a source-backed observation.

Transparent record

Activity and accepted changes

Accepted researcher context, editorial status, public discussion, and upstream Git revisions are shown together. Pending, declined, and withdrawn proposals remain private.

10 events
  1. published revision

    Backfill butyrate concept links

    Karen Pendergrass · +1 −1

    Inspect exact Git diff ↗
  2. published revision

    Backfill inflammation concept links

    Karen Pendergrass · +2 −2

    Inspect exact Git diff ↗
  3. published revision

    Complete corpus-wide Dysbiosis linking

    Karen Pendergrass · +2 −2

    Inspect exact Git diff ↗
  4. published revision

    Add Interleukin-22 concept and contextual links

    Karen Pendergrass · +1 −1

    Inspect exact Git diff ↗
  5. published revision

    massive wiki expansion: 149 stubs fixed, 100+ new pages, Rule 15 scan, keystone papers

    WikiBiome Deploy Bot · +98 −92

    Inspect exact Git diff ↗
  6. published revision

    nightly maintenance: 94 stub demotions, 181 source_count fixes, 22 auto-discovered stubs, 5 adversarial audits, 3 boundary fixes, 3 evidence-level corrections

    WikiBiome Deploy Bot · +3 −0

    Inspect exact Git diff ↗
  7. published revision

    WikiBiome update — 2026-04-15 17:23

    WikiBiome Deploy Bot · +21 −21

    Inspect exact Git diff ↗
  8. published revision

    wiki: bulk entity upgrades, new article pages, and site regeneration

    WikiBiome Deploy Bot · +6 −0

    Inspect exact Git diff ↗
  9. published revision

    WikiBiome update — integrity fixes, metallomic diet pages, cross-condition analyses

    WikiBiome Deploy Bot · +31 −29

    Inspect exact Git diff ↗
  10. published revision

    WikiBiome update — 2026-04-10 17:16

    WikiBiome Deploy Bot · +198 −0

    Inspect exact Git diff ↗
Continue exploring

Every article is a doorway.

Generated from the WikiBiome Markdown vault and reconciled against its source registry.

8 references · 5 backlinks · 10 indexed topics